Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk [NA]

View source ↗

Summary

Clinical trial evaluating allogeneic hematopoietic stem cell transplantation in patients with low-risk myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: MDS | NA | Status: COMPLETED